Limitations, agreements, and source contact

A Dose Escalation Study of Carfilzomib Taken With Thalidomide and Dexamethasone in Relapsed AL Amyloidosis · Source last updated 2021-04-15

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

false

restrictive Agreement

false

limitations And Caveats

description

The trial closed to recruitment following the dose escalation stage without opening the expansion phase due to slow recruitment.

point Of Contact

email

medcatal@leeds.ac.uk

organization

Leeds Institute of Clinical Trials Research

phone

0113 343 9077

title

Alexandra Pitchford

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice